Childhood GHD

Background

Experts identified by the GloBE-Reg Steering Committee were invited to form the first Expert Working Group (EWG) and that was for Childhood GHD in early 2022. The Childhood GHD EWG completed its activities in Spring 2024.

Members

Activities

  1. Development of the minimum dataset (MDS) for monitoring safety and effectiveness of rhGH in Childhood GHD
  2. Advising on the addition of the above MDS in the GloBE-Reg Registry
  3. Performing a systematic review of safety and effectiveness outcomes that are assessed for rhGH therapy in childhood GHD
  4. Advise on the development of new EWGs and studies

Achievements

Minimum Dataset
Minimum Dataset Publication
Systematic Review of Core Outcomes – Preliminary Results
Development of New Studies
Development of New Expert Working Groups

Last Modified